John Lansing's Trending123
John Lansing's Trending123
Username: Password: Login
Products & Services Trading Tools Portfolios Members Home
Enter Symbol:
OSI PHARMACEUTICALS INC
Biotechnology
OSIP @ Yahoo Finance
OSIP Option @ Yahoo Finance
Latest Quote @ Sat Nov 21 01:45:49 (15 min delayed)
Bid Ask Last Change $ Change % Volume
$31.83 $33.65 $32.79 -0.07 -0.21% 346,990
Last Day's Data
Closing Price High Value Change Percent Change Dividend Previous Close
$ 32.79 $ 33.05 $ -0.07 -0.21% 0.00 $ 32.86
Opening Price Low Volume Market Cap Average Volume P/E
$ 33.01 $ 32.50 346,990 1.9B 856,308 5.10
Pivot Table
R2 R1 Pivot S1 S2
33.33 33.06 32.78 32.51 32.23

stock chart

OSI Pharmaceuticals, Inc., a biotechnology company, engages in the discovery, development, and commercialization of oncology products for cancer patients in the United States. Its flagship product, Tarceva, is an oral, once-a-day, small molecule inhibitor of the epidermal growth factor receptor. The company also markets Novantrone for the approved oncology indications; and Gelclair for the relief of pain associated with oral mucositis. Its other drug candidates include OSI-7904L, a liposomal formulation of a potent thymidylate synthase inhibitor, which is in phase II study; OSI-461, an inhibitor of cGMP phosphodiesterases, which is in phase I dose optimization study; and OSI-930, a tyrosine kinase inhibitor, which is in preclinical research stage. In addition, OSI Pharmaceuticals, through its collaborative drug discovery program, develops CP-547,632, which targets vascular endothelial growth factor receptor and is in Phase II and Phase I trials; CP-868,596 that targets tumor derived angiogenesis and is in Phase I trials; and CP-724,714, which is an oral inhibitor of epidermal growth factor receptor 2 and is in Phase I clinical trial. Further, its subsidiary, Prosidion Limited, specializes in diabetes and obesity treatment in the United Kingdom. The company has collaboration agreements with Pfizer, Inc.; Cold Spring Harbor Laboratory; EiRX Therapeutics plc; Genentech, Inc.; PR Pharmaceuticals, Inc.; and Roche. OSI Pharmaceuticals is headquartered in Melville, New York.
  • Premarket, intraday, nightly, and weekend updates, which include stock picks with full instructions, market direction (short, intermediate, long term), precious metal, commodity, and currency analysis.
  • Provide you stock picks (breakouts) and market direction to help you become
    more profitable.

  • Voice over chart updates sent to you by e-mail. These updates contain stock picks and market status for a number of different portfolios, which Trending123 is recommending and following.
  • Instantaneous e-mail alerts during the trading day when targets have been hit or the status of a position or the market warrants a move. Stock Recommendations for swing traders, day traders, and long term investors.
  • Receive instant emails to your computer, organizer, cell phone of breakouts on stocks.....Learn More